- 【Updated on January 20, 2026】 Integration of CiNii Books into CiNii Research
- Trial version of CiNii Research Knowledge Graph Search feature is available on CiNii Labs
- 【Updated on November 26, 2025】Regarding the recording of “Research Data” and “Evidence Data”
- Incorporated Jxiv preprints from JaLC and adding coverage from NDL Search
Association of Aggression and Antiepileptic Drugs: Analysis Using the Japanese Adverse Drug Event Report (JADER) Database
-
- Kawada Kei
- Graduate School of Integrated Arts and Sciences, Kochi University Department of Pharmacy, Kochi Medical School Hospital
-
- Ishida Tomoaki
- Department of Pharmacy, Kochi Medical School Hospital
-
- Jobu Kohei
- Department of Pharmacy, Kochi Medical School Hospital
-
- Ohta Tsuyoshi
- Department of Neurosurgery, National Cerebral and Cardiovascular Center Hospital
-
- Fukuda Hitoshi
- Department of Neurosurgery, Kochi Medical School, Kochi University
-
- Morisawa Shumpei
- Graduate School of Integrated Arts and Sciences, Kochi University Department of Pharmacy, Kochi Medical School Hospital
-
- Kawazoe Tetsushi
- Graduate School of Integrated Arts and Sciences, Kochi University Department of Pharmacy, Kochi Medical School Hospital
-
- Tamura Naohisa
- Graduate School of Integrated Arts and Sciences, Kochi University Department of Pharmacy, Kochi Medical School Hospital
-
- Miyamura Mitsuhiko
- Graduate School of Integrated Arts and Sciences, Kochi University Department of Pharmacy, Kochi Medical School Hospital
Bibliographic Information
- Published
- 2022-06-01
- Resource Type
- journal article
- DOI
-
- 10.1248/bpb.b21-00954
- Publisher
- The Pharmaceutical Society of Japan
Search this article
Description
<p>Aggression is the most common adverse effect of antiepileptic drugs (AEDs). This study aimed to investigate the association of aggression with AED use. The reporting odds ratio (ROR) from adverse event reports, submitted to the Japanese Adverse Drug Event Report database between 2004 and 2020, was used to calculate and investigate the association between AEDs and aggression. We also analyzed the association of aggression with the combined use of AEDs and the relationship between AED-associated aggression and patient characteristics. A total of 433 patients developed aggression. Significant aggression signals were detected for perampanel (crude ROR: 325.04, 95% confidence interval (CI): 118.48–752.58, p < 0.01), levetiracetam (crude ROR: 17.14, 95% CI: 10.33–26.90, p < 0.01), lacosamide (crude ROR: 16.90, 95% CI: 2.02–62.51, p < 0.01), lamotrigine (crude ROR: 15.98, 95% CI: 9.99–24.39, p < 0.01), valproate (crude ROR: 6.68, 95% CI: 4.27–10.02, p < 0.01), and carbamazepine (crude ROR: 2.47, 95% CI: 1.17–4.59, p < 0.01). The combined therapy with perampanel and levetiracetam had a significant aggression signal (adjusted ROR: 25.90, 95% CI: 1.14–59.10, p < 0.01). In addition, we found that aggression frequently occurred in patients <60 year (adjusted ROR: 2.88, 95% CI: 1.49–5.56, p < 0.01) treated with levetiracetam. These results may be useful for minimizing the risk of aggression during the treatment of AEDs.</p>
Journal
-
- Biological and Pharmaceutical Bulletin
-
Biological and Pharmaceutical Bulletin 45 (6), 720-723, 2022-06-01
The Pharmaceutical Society of Japan